V International Symposium on Inflammatory Bowel DiseasesD. Rachmilewitz This book, the proceedings of the V International Symposium on Inflammatory Bowel Diseases (Falk Symposium 101) held in Tel-Aviv, Israel, on September 22-24, 1997, is devoted to inflammatory bowel diseases towards the 21st century. The achievements of the last fifty years, medical, surgical and in the basic sciences, are summarized in detail. Controversies with respect of the aetio-pathogenesis of inflammatory bowel diseases are discussed together with pending clinical controversies, such as the best way to monitor treatment, early versus late surgery, post-operative maintenance and surveillance. A special section is devoted to clarification of for whom each of the available drugs is the drug of choice. Finally, a large section deals with surgical controversies, such as laparoscopic surgery in inflammatory bowel diseases, one- versus two-stage ileo-anal anastomosis and treatment of fistula in Crohn's disease. The last section outlines needs, both in the medical sciences and in the clinic. |
From inside the book
49 pages matching active Crohn's disease in this book
Where's the rest of this book?
Results 1-3 of 49
Contents
medical achievements 19471997 | 3 |
what have we achieved? | 18 |
What has science provided over the last 50 years? | 25 |
Copyright | |
18 other sections not shown
Common terms and phrases
acid active acute anastomosis antibodies antigens approach associated azathioprine bacteria benefit budesonide cancer cells chronic clinical colectomy colon compared complete complications controlled trial Crohn's disease cyclosporine cytokines decreased demonstrated dose drug dysplasia early effective efficacy endoscopic enemas et al evidence experience factor fistulas function Gastroenterol Gastroenterology genes genetic given human ileostomy immune important improvement increased indications inflammation inflammatory bowel disease initial intestinal intravenous laparoscopic lesions less levels long-term maintenance major mediators metronidazole mice models months mucosal normal occur operation oral patients performed placebo possible postoperative pouch prednisolone present procedure production randomized recent rectal recurrence relapse remission reported resection response risk role severe showed shown significant smoking specific steroids suggested Surg surgery surgical surveillance systemic Table therapeutic therapy treated treatment ulcerative colitis versus